BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12767991)

  • 1. Mechanisms of avian retroviral host range extension.
    Rainey GJ; Natonson A; Maxfield LF; Coffin JM
    J Virol; 2003 Jun; 77(12):6709-19. PubMed ID: 12767991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor.
    Holmen SL; Melder DC; Federspiel MJ
    J Virol; 2001 Jan; 75(2):726-37. PubMed ID: 11134286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of an avian retrovirus mutant with extended receptor usage.
    Taplitz RA; Coffin JM
    J Virol; 1997 Oct; 71(10):7814-9. PubMed ID: 9311868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.
    Melder DC; Pike GM; VanBrocklin MW; Federspiel MJ
    J Virol; 2015 Feb; 89(4):2136-48. PubMed ID: 25473063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in Both the Surface and Transmembrane Envelope Glycoproteins of the RAV-2 Subgroup B Avian Sarcoma and Leukosis Virus Are Required to Escape the Antiviral Effect of a Secreted Form of the Tvb
    Yin X; Melder DC; Payne WS; Dodgson JB; Federspiel MJ
    Viruses; 2019 May; 11(6):. PubMed ID: 31159208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two different molecular defects in the Tva receptor gene explain the resistance of two tvar lines of chickens to infection by subgroup A avian sarcoma and leukosis viruses.
    Elleder D; Melder DC; Trejbalova K; Svoboda J; Federspiel MJ
    J Virol; 2004 Dec; 78(24):13489-500. PubMed ID: 15564460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors.
    Valsesia-Wittmann S; Drynda A; Deléage G; Aumailley M; Heard JM; Danos O; Verdier G; Cosset FL
    J Virol; 1994 Jul; 68(7):4609-19. PubMed ID: 8207835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of a hypervariable region within the hr2 domain of the host range determining sequences of the envelope protein gp85 (SU) of subgroup-A avian sarcoma-leukosis viruses.
    Hara H; Tanaka A; Kaji A
    Virus Genes; 1996; 12(1):37-46. PubMed ID: 8879119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary pressure of a receptor competitor selects different subgroup a avian leukosis virus escape variants with altered receptor interactions.
    Melder DC; Pankratz VS; Federspiel MJ
    J Virol; 2003 Oct; 77(19):10504-14. PubMed ID: 12970435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses.
    Zingler K; Young JA
    J Virol; 1996 Nov; 70(11):7510-6. PubMed ID: 8892869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of the Rous sarcoma virus subgroup D env gene: mammal tropism correlates with temperature sensitivity of gp85.
    Bova-Hill C; Olsen JC; Swanstrom R
    J Virol; 1991 Apr; 65(4):2073-80. PubMed ID: 1848317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant and recombinant avian retroviruses with extended host range.
    Tsichlis PN; Conklin KF; Coffin JM
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):536-40. PubMed ID: 6244565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avian Sarcoma and Leukosis Virus Envelope Glycoproteins Evolve to Broaden Receptor Usage Under Pressure from Entry Competitors
    Munguia A; Federspiel MJ
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31195660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single glycosylation site within the receptor-binding domain of the avian sarcoma/leukosis virus glycoprotein is critical for receptor binding.
    Delos SE; Burdick MJ; White JM
    Virology; 2002 Mar; 294(2):354-63. PubMed ID: 12009877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Region coding for subgroup specificity of envelope of avian retroviruses does not determine lymphomagenicity.
    Wright SE; Bennett DD
    Virus Res; 1986 Nov; 6(2):173-80. PubMed ID: 2432740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of a subgroup A avian leukosis virus [ALV(A)] envelope resistant to soluble ALV(A) surface glycoprotein.
    Holmen SL; Federspiel MJ
    Virology; 2000 Aug; 273(2):364-73. PubMed ID: 10915607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
    Netter RC; Amberg SM; Balliet JW; Biscone MJ; Vermeulen A; Earp LJ; White JM; Bates P
    J Virol; 2004 Dec; 78(24):13430-9. PubMed ID: 15564453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and biological characterization of a naturally occurring recombinant subgroup B avian leukosis virus with a subgroup J-like long terminal repeat.
    Lupiani B; Pandiri AR; Mays J; Hunt HD; Fadly AM
    Avian Dis; 2006 Dec; 50(4):572-8. PubMed ID: 17274296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The avian retrovirus env gene family: molecular analysis of host range and antigenic variants.
    Bova CA; Olsen JC; Swanstrom R
    J Virol; 1988 Jan; 62(1):75-83. PubMed ID: 2824857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in susceptibility to avian sarcoma viruses and expression of endogenous avian leukosis virus antigens in specific pathogen-free chicken lines.
    Ignjatovic J; Bagust TJ
    J Gen Virol; 1985 Aug; 66 ( Pt 8)():1723-31. PubMed ID: 2991436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.